SIMR   Report issue

For profit Phase 1
Founded: Shanghai China (2014)

Organization Overview

First Clinical Trial
2019
NCT04021563
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Shanghai Simnova Biotechnology Co.,Ltd. | SIMR | SIMR (Australia) Biotech Pty Ltd | SIMR (Australia) Biotech Pty Ltd.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuralgia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 9
  • # of Trial APIs: 9